Form 4: Corcept Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Sean Maduck, See Remarks of Corcept Therapeutics Inc, sold 1,031 shares of common stock on August 10, 2026 for $114.52 per share.
Summary
- Option exercise/conversion: acquired 1,031 Common Stock at $8.27 ($8,526) on August 10, 2026; holds 10,786 after (Direct).
- Open-market sale: disposed of 1,031 Common Stock at $114.52 ($118,068) on August 10, 2026; holds 9,755 after (Direct).
- Option exercise/conversion: disposed of 1,031 Stock option (right to buy) on August 10, 2026; holds 95,650 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $118,068 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Sean Maduck — Officer (See Remarks)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-10 | Option exercise/conversion | Common Stock | 1,031 | $8 | $8.5K | 10,786 |
| 2026-08-10 | Open-market sale | Common Stock | 1,031 | $115 | $118.1K | 9,755 |
| 2026-08-10 | Option exercise/conversion | Stock option (right to buy) | 1,031 | — | — | 95,650 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-10 | Option exercise/conversion (1,031 shares) |
| 2026-08-10 | Open-market sale (1,031 shares) |
| 2026-08-10 | Option exercise/conversion (1,031 shares) |
Keywords
insider transaction, Form 4, CORT, CORCEPT THERAPEUTICS INC, bearish, Sean Maduck
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.